Skip to content

Minerva Endometrial Ablation System

by Axora Medical, Inc. PMA

Active United States

PMA P140013

Overview

The Minerva Endometrial Ablation System is a Class III thermal ablation device designed for endometrial ablation. It is indicated for the ablation of the endometrial lining in pre-menopausal women with menorrhagia caused by benign conditions, where childbearing is complete. The system employs simultaneous thermal energy modalities to achieve consistent tissue coverage.

This device is supplied sterile and intended for single-use. It is regulated under an FDA Premarket Approval (PMA) and falls under the Obstetrics/Gynecology advisory committee category. The system is engineered for use in clinical settings and requires proper handling and storage as per manufacturer guidelines to maintain sterility and functionality.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP140013 Date27 Jul 2015ApprovedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA PMA Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

PMA

Generic Name
Device, thermal ablation, endometrial
PMA Number
FDA Product Code
MNB
Device Class
Class III
Advisory Committee
Obstetrics/Gynecology
FDA Decision
APPR Approved

Other devices from Axora Medical, Inc.

Questions

  • What is the Minerva Endometrial Ablation System used for in clinical practice?

    The Minerva Endometrial Ablation System is specifically designed for endometrial ablation, which is the removal or destruction of the endometrial lining in the uterus. It is intended for pre-menopausal women who experience menorrhagia (excessive menstrual bleeding) due to benign conditions and have completed childbearing. The system uses thermal energy to achieve consistent ablation of the endometrial lining, helping to reduce or eliminate heavy bleeding.

  • Is the Minerva Endometrial Ablation System intended for reuse or is it single-use?

    The Minerva Endometrial Ablation System is explicitly supplied sterile and intended for **single-use only**. This design ensures patient safety and maintains sterility, as reuse could compromise its integrity and potentially introduce infection risks.

  • How should the Minerva Endometrial Ablation System be stored to preserve its functionality?

    The device must be stored according to the manufacturer’s guidelines to maintain sterility and functionality. Since it is sterile upon supply and single-use, it should be kept in its original packaging until use, protected from contamination, moisture, and extreme temperatures. Improper storage could compromise its performance or sterility.

  • What regulatory pathway does the Minerva Endometrial Ablation System follow?

    The Minerva Endometrial Ablation System is regulated under the **FDA Premarket Approval (PMA)** pathway, which is required for Class III devices. This approval was granted through the Obstetrics/Gynecology advisory committee, confirming its compliance with rigorous safety and effectiveness standards for endometrial ablation procedures.